PRELUDE THERAPEUTICS INC

PRLD ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
PRE 14A Apr 11, 2025 PRE 14A
4 Apr 7, 2025 PRIMARY DOCUMENT
8-K Mar 28, 2025 8-K
4 Mar 27, 2025 PRIMARY DOCUMENT
4 Mar 27, 2025 PRIMARY DOCUMENT
4 Mar 24, 2025 PRIMARY DOCUMENT
4 Mar 18, 2025 PRIMARY DOCUMENT
4 Mar 14, 2025 PRIMARY DOCUMENT
S-8 Mar 10, 2025 S-8
10-K Mar 10, 2025 10-K
8-K Mar 10, 2025 8-K
SCHEDULE 13G/A Feb 14, 2025
SCHEDULE 13G/A Feb 13, 2025
4 Feb 5, 2025 PRIMARY DOCUMENT
4 Feb 5, 2025 PRIMARY DOCUMENT
4 Feb 5, 2025 PRIMARY DOCUMENT
4 Feb 5, 2025 PRIMARY DOCUMENT
4 Feb 5, 2025 PRIMARY DOCUMENT
8-K Feb 5, 2025 8-K
4 Jan 7, 2025 PRIMARY DOCUMENT
4 Jan 3, 2025 PRIMARY DOCUMENT
4 Jan 2, 2025 PRIMARY DOCUMENT
4 Dec 26, 2024 PRIMARY DOCUMENT
4 Dec 20, 2024 PRIMARY DOCUMENT
4 Dec 20, 2024 PRIMARY DOCUMENT
← Newer Page 4 of 16 · 389 filings Older →